SUNIC SYSTEM Co., Ltd. (KOSDAQ:171090)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	352,780	364,662	253,518	188,536	189,488	60,135
Market Cap Growth	-3.57%	43.84%	34.47%	-0.50%	215.10%	-11.31%
Enterprise Value	354,277	323,636	249,977	191,158	165,749	39,476
Last Close Price	40000.00	41650.00	29350.00	22150.00	22800.00	7246.76
PE Ratio	-	-	-	-	-	25.96
PS Ratio	3.16	3.23	4.06	2.55	4.10	0.92
PB Ratio	8.11	7.86	3.58	2.38	2.36	0.66
P/TBV Ratio	8.29	8.02	3.63	2.41	2.40	0.67
P/FCF Ratio	-	-	65.03	-	-	7.82
P/OCF Ratio	-	-	45.47	-	-	4.60
EV/Sales Ratio	3.18	2.87	4.01	2.58	3.59	0.60
EV/EBITDA Ratio	28.81	25.45	955.36	23.98	-	7.55
EV/EBIT Ratio	48.76	40.93	-	43.10	-	10.73
EV/FCF Ratio	-14.20	-	64.12	-	-	5.13
Debt / Equity Ratio	1.79	1.66	0.32	0.29	0.02	0.01
Debt / EBITDA Ratio	6.34	6.05	87.36	2.90	-	0.20
Debt / FCF Ratio	-	-	5.86	-	-	0.13
Asset Turnover	0.45	0.52	0.48	0.65	0.44	0.58
Inventory Turnover	0.91	1.35	2.75	5.58	5.87	6.54
Quick Ratio	0.31	0.41	0.72	1.06	1.71	2.60
Current Ratio	1.03	1.05	1.59	1.89	2.80	3.86
Return on Equity (ROE)	-42.56%	-47.86%	-12.29%	-4.06%	-11.96%	2.56%
Return on Assets (ROA)	1.83%	2.26%	-1.95%	2.44%	-4.24%	2.02%
Return on Capital (ROIC)	4.33%	4.55%	-2.59%	3.02%	-5.14%	2.50%
Return on Capital Employed (ROCE)	10.80%	11.00%	-	5.40%	-	4.00%
Earnings Yield	-6.45%	-7.70%	-3.64%	-1.72%	-5.39%	3.85%
FCF Yield	-7.07%	-13.50%	1.54%	-7.49%	-7.06%	12.79%
Payout Ratio	-	-	-	-	-	37.19%
Buyback Yield / Dilution	-1.30%	-1.54%	-1.69%	-2.13%	1.45%	2.39%
Total Shareholder Return	-	-1.54%	-1.69%	-2.13%	1.45%	2.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.